Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
4 registered trials, newest registry update first. Showing only trials linked to Brenipatide.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A Study of Brenipatide in Participants With Alcohol Use Disorder NCT07219953 | Brenipatide | Phase 3 | Recruiting | Eli Lilly and Company | 1,100 | Apr 2028 | Nov 4, 2026 |
| A Study of Brenipatide in Adult Participants With Major Depressive Disorder NCT07412756 | Brenipatide | Phase 3 | Recruiting | Eli Lilly and Company | 1,000 | Feb 2028 | Nov 4, 2026 |
| A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder NCT07219966 | Brenipatide | Phase 3 | Recruiting | Eli Lilly and Company | 1,100 | Apr 2028 | Oct 7, 2026 |
| A Study of LY3537031 in Overweight, Obese, and Healthy Participants NCT06606106 | Brenipatide | Phase 1 | Active not recruiting | Eli Lilly and Company | 302 | Nov 2026 | Sep 30, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.